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This study sought to investigate if acute phase immune responses of whole blood from
Peruvian children with controlled and uncontrolled asthma differed from children without
asthma, following exposure to traffic-related particulate matter (TRPM). TRPM, including
particulate matter from diesel combustion, has been shown to stimulate acute airway
inflammation in individuals with and without asthma. For this study, a whole blood assay
(WBA) was used to test peripheral whole blood samples from 27 children with asthma,
and 12 without asthma. Participant blood samples were stimulated, ex vivo, for 24-h
with an aqueous extract of TRPM that was collected near study area highways in Lima,
Peru. All participant blood samples were tested against the same TRPM extract, in
addition to purified bacterial endotoxin and pyrogen-free water, which served as positive
and negative WBA controls, respectively. The innate and adaptive cytokine responses
were evaluated in cell-free supernatants of the whole blood incubations. Comparatively
similar levels were recorded for nine out of the 10 cytokines measured [e.g., – Interleukin
(IL)-1β, IL-6, IL-10], regardless of study participant asthma status. However, IL-8 levels
in TRPM-stimulated blood from children with uncontrolled asthma were diminished,
compared to subjects without asthma (633 pg/ml vs. 1,023 pg/ml, respectively;
p < 0.01); IL-8 responses for subjects with controlled asthma were also reduced,
but to a lesser degree (799 pg/ml vs. 1,023 pg/ml, respectively; p = 0.10). These
relationships were present before, and after, adjusting for age, sex, obesity/overweight
status, C-reactive protein levels, and residential proximity to the study area’s major
roadway. For tests conducted with endotoxin, there were no discernible differences
in cytokine response between groups, for all cytokines measured. The WBA testing
conducted for this study highlighted the capacity of the TRPM extract to potently
elicit the release of IL-8 from the human whole blood system. Although the small
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sample size of the study limits the capacity to draw definitive conclusions, the IL-8
responses suggest that that asthma control may be associated with the regulation of
a key mediator in neutrophil chemotaxis, at a systemic level, following exposure to PM
derived from traffic-related sources.
Keywords: asthma, particulate matter, whole blood assay, inflammation, cytokines
INTRODUCTION
Asthma is a respiratory disease characterized by recurrent
episodes of airway inflammation, bronchial hyperreactivity,
increased mucus production, and airflow obstruction (Hedlin
et al., 2012; Ji et al., 2016). These symptoms may vary
broadly in severity (Ray et al., 2016). Although asthma is
classically associated with atopic phenotypes, and sensitization to
aeroallergens, it has been estimated that only one-half of all cases
are mediated by allergic, eosinophilic responses (Pearce et al.,
1999; Douwes et al., 2011; Brooks et al., 2016). Consequently,
there is interest in evaluating the potential of non-allergenic
constituents from environmental particulate matter (PM) to
trigger a worsening of asthma control (Guarnieri and Balmes,
2014; Ji et al., 2016). Respiratory exposures to PM containing such
agents [e.g., – transition metals, poly-aromatic hydrocarbons
(PAHs), ultrafine and nanoparticles, endotoxin], may stimulate
conserved, acute-phase inflammatory activity that results in
asthmatic symptoms via the production of reactive oxygen
species (ROS), cytokine release, and immune cell recruitment
(Williams et al., 2005; Al-Daghri et al., 2013; DeKruyff et al., 2014;
Li et al., 2016).
Traffic-related PM (TRPM), including PM from diesel
combustion sources, has been shown to stimulate acute
airway inflammation in individuals with and without asthma
(McCreanor et al., 2007; Zhang et al., 2009; Delfino et al., 2013;
Alexis and Carlsten, 2014; Ji et al., 2016). TRPM exposure is
regarded as an important risk factor for the development of
childhood asthma, with supporting epidemiological evidence for
increased prevalence of asthma morbidity amongst children who
live near major highways (Venn et al., 2001; McConnell et al.,
2006; Escamilla-Nuñez et al., 2008). Near roadways and urban
areas, particles with aerodynamic equivalent diameters≤ 2.5 µm
(PM2.5) are primarily derived from combustion sources and have
been associated with elevated risks of asthma and respiratory
inflammation (Lee et al., 2006; Perez et al., 2012; Evans et al.,
2014; Bowatte et al., 2015). Two other common traffic pollutants,
ozone and nitrogen dioxide (NO2), have similarly been reported
in mechanistic studies to stimulate acute inflammatory immune
activity through ROS and oxidative stress (Bayram et al., 2001;
Mirowsky et al., 2013; Wu et al., 2013). Like PM2.5, the asthma
risks of ozone and NO2 are support by a variety of epidemiologic
studies, which have been conducted in populations across the
World (Lee et al., 2006; Alexis and Carlsten, 2014; Nishimura
et al., 2016; Tétreault et al., 2016).
Ambient concentrations of PM2.5 and black carbon
(BC) (a marker of combustion) have been found to
persist within 75 – 100 meters (m) of highway traffic, and
decrease to background levels after distances of 150 – 300 m
(Hitchins et al., 2000; Zhu et al., 2002; Kozawa et al., 2012). The
capacity for these particles to transport over long distances in
the environment and deposit in the sensitive alveolar regions
of the respiratory system has further fueled interest in their
pro-inflammatory potential (Pope and Dockery, 2006). PM2.5
may also contain a high fraction of ultrafine and nano-scale
particles, which are considered to be capable of translocating to
the blood stream via respiratory exposure (Nemmar et al., 2004).
However, the task of evaluating the immunomodulatory
characteristics of TRPM exposures is complicated by the
inherently heterogeneous composition of anthropogenic,
biologic, and crustal elements that may comprise the TRPM
matrix (Kenyon and Liu, 2011; Esposito et al., 2014b). TRPM
may carry a range of possible immunostimulatory, combustion-
derived components (e.g., – PAHs and transition metals), in
addition to bioaerosol constituents (Lighty et al., 2000; Sioutas
et al., 2005). Both PAHs and transition metals are hallmarks of
TRPM (Jeng, 2010; Pardo et al., 2015; Shuster-Meiseles et al.,
2016). Currently, the immunologic response to TRPM from
any single environment remains to be fully elucidated, which
has limited the research community’s capacity to determine
if children with asthma carry enhanced susceptibilities to
TRPM-induced inflammation, as compared to children without
asthma. Emerging in vitro methods, such as the human whole
blood assay (WBA), offer opportunities to holistically assess
the immunostimulatory activity of complex exposures (e.g., –
TRPM) within integrated host-specific biologic systems.
In Peru, the prevalence of childhood asthma is among the
highest of all Latin American countries (Mallol et al., 2000).
Lima, Peru’s capitol and economic center, has developed into an
expansive population center, with estimated 8.5 million people,
where pervasive exposures to traffic pollutants occur throughout
the city center and peripheral communities. Here, TRPM
exposures may serve as a significant environmental mediator
in the observed asthma morbidity. The present study was
conducted in Pampas de San Juan de Miraflores (Pampas), one
of the many densely populated peri-urban neighborhoods that
surround Lima. Previous epidemiologic investigations conducted
in Pampas by Baumann et al. (2011) indicated that children living
within 100 m of a major community roadway, where mobile
source emissions were most dense, carried twice the odds of
reporting current asthma symptoms, compared to children living
in homes distant to the road (384 m or more). Environmental
monitoring was conducted in Pampas by Underhill et al. (2015),
who then reported that the levels of PM2.5, black carbon, and
NO2 within the indoor air of neighborhood households were
often equivalent to levels detected outside of the home, in
the ambient air, suggesting these traffic-related pollutants easily
permeated the home environment.
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For this study, we utilized a human WBA to evaluate
the potential of ambient PM from this neighborhood to
stimulate conserved inflammatory immune responses, and tested
peripheral whole blood from local children with and without
asthma. The WBA served as a unique field-applicable test with
which to test individual immune responses to both standard
inflammatory agents (e.g., – purified endotoxin) and complex
environmental matrices (TRPM) from the local study area
environment. The cytokine responses generated in the WBA were
contrasted among groups of subjects, with and without asthma, in
order to determine if asthma status (e.g., – no asthma, controlled
asthma, uncontrolled asthma) was associated with an altered
acute phase immune activity. The human whole blood system
serves as a suitable reaction medium for this work as it carries an
array of immunologic defense mechanisms (e.g., – innate pattern
recognition receptors, complement) that recognizes a wide array
of biologically relevant stimuli (Fennrich et al., 1999; Kindinger
et al., 2005; Hasiwa et al., 2013; Klümper et al., 2015). Moreover,
the WBA maintains the physiologic composition of the donor
whole blood system (e.g., – leukocyte subpopulations, antibodies,
soluble factors), and allows immune cells to respond to stimuli
in their evolved cellular and molecular context (Hartung and
Wendel, 1995; Schins et al., 1996).
Pro-inflammatory stimulation of whole blood results in a
complex immunologic cascade that includes the rapid release
of acute phase mediators (e.g., – TNFα, IL-1β, IL-6) from
blood monocytes, increased cellular phagocytic activity, and
the production of ROS (Mogensen, 2009; Takeuchi and Akira,
2010). The ex vivo incubation of human whole blood with
environmental PM is an approach that is similar to other
studies, which have employed monocytic cell lines and isolated
peripheral blood mononuclear cells (PMBCs) to assess the
cytokine inducing potential of air pollutants (Monn and Becker,
1999; Alfaro-Moreno et al., 2002; Osornio-Vargas et al., 2003).
While this WBA method was originally developed to test for the
presence of pyrogenic (i.e., – fever inducing) contamination in
pharmaceutical and injectable drugs, it has since been adapted
for the monitoring of immunomodulatory treatments (Hartung
et al., 1995), the characterization of the immune status of patient
groups (Diterich et al., 2001), and for environmental air quality
analysis, as a novel means toward assessing the inflammatory
cytokine-inducing potential of complex PM samples (Kindinger
et al., 2005; Liebers et al., 2009; Bernasconi et al., 2010).
More recently, Klümper et al. (2015), utilized a WBA approach
to aid in evaluating if asthma status modified the effects of
air pollution exposure on whole blood cytokine response to a
standard PM sample. However, the PM used in the Klümper et al.
(2015) study was a standard (EHC-93) collected from Ottawa,
Canada, in 1993, while the air quality measurements and study
subjects were located in Wesel, Germany. Thus, the PM was not
native to the subject’s local environment.
For the present study, PM2.5 was sampled from ambient air
in the Pampas study area, at locations adjacent to the roadways
that cut through the neighborhood from which our subjects were
recruited. We collected filter samples of this PM and developed
a single aqueous extract of stimuli for WBA tests, which were
conducted using blood donations from children with and without
asthma. Acute phase cytokine release was measured in peripheral
whole blood, following 24-h of ex vivo exposure to TRPM
extract, under controlled conditions. Post-incubated blood was
assessed for a panel of cytokines that reflected innate and adaptive
responses.
Our primary hypothesis was that levels of TRPM-stimulated
acute phase inflammatory cytokines, associated with the innate
immune response, would be enhanced in whole blood from
children with either controlled or uncontrolled asthma, as
compared to blood from children without asthma.
MATERIALS AND METHODS
Ethics Statement
The Institutional Review Boards of the Johns Hopkins University
(JHU) School of Medicine (Baltimore, MD, USA) (Study #
CIR00007480) and A.B. PRISMA (Lima, Peru) approved this
study. Written informed consent for participation was obtained
from the parents or guardians of each participant and assent was
obtained from children.
Study Site and Population
Pampas de San Juan de Miraflores is a peri-urban Peruvian
neighborhood, located 25 km south of Lima’s city center (see
Figure 1). The Pampas community encompassed low-to-middle
income households, with a dense population of approximately
60,000 people (Robinson et al., 2012). Participants were recruited
from a longitudinal cohort study [Genetic susceptibility to
Asthma and Air Pollution Study in Peru (GASP)]. Overall, 45
children (ages 11–19) were enrolled in our study between March
and June of 2014 (30 with persistent asthma and 15 controls).
Enrollment was limited to one child per household and the
general exclusion criteria for participants in this study included:
current pregnancy, bacterial or viral infection in the past week,
diagnosis of a chronic respiratory disease other than asthma
(e.g., – tuberculosis, cystic fibrosis). Subjects were recruited from
homes that were located either within 75 m of the major four-
lane roadway in the study area, or at distances of 150 m away or
greater, with the intent to enroll equal numbers of subjects living
near-to and far from the roadway. Thus, the study participants do
not represent a random sample from the larger GASP cohort.
Subjects with persistent asthma, and healthy controls without
asthma, were confirmed based on responses recorded from a
validated Asthma Screening Questionnaire (ASQ), as well as
baseline spirometry tests (FEV1/FVC) conducted during the
GASP study (collected between August of 2011 and March of
2012). The ASQ contained asthma severity questions that were
derived from the International Study on Asthma and Allergies
in Childhood (ISAAC) (Ellwood et al., 2005), and guidance from
National Asthma Education and Prevention Program’s Expert
Panel Report 3 (National Asthma Education and Prevention
Program, 2007). Participants with a score < = 19 on the Asthma
Control Test (ACT) were categorized as having “uncontrolled”
asthma, while subjects with an ACT score ≥ 20 and <25
were considered to have “controlled” asthma. Children without
asthma, or other respiratory disease, were selected as controls
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FIGURE 1 | Map of Pampas de San Juan de Miraflores location in Lima, and study area limits in relation to the highway.
for the study. Questionnaire data was collected on personal
tobacco cigarette use at time of enrollment in the GASP study and
medication (oral and inhaled corticosteroid) use was collected in
the 2 weeks prior to blood collection.
Atopy status was determined with an ImmunoCAP Phadiatop
test (IummunoCAP 250-ThermoFisher Scientific, Inc.), based
on three panels of allergens (animal epidermal proteins, house
dust, and a mold and yeast mix). A positive result (IgE > 0.1
kUa/L) to any of the allergen panels was considered atopic.
Height and weight were measured and body mass index (BMI)
was calculated in kg/m2. Our analysis also categorized children
as overweight/obese vs. normal weight, based on BMI thresholds
developed by Cole et al. (2000).
Collection and Preparation of TRPM
Stimuli
Prior to the enrollment of subjects, TRPM was sampled from
ambient air at five different locations within the Pampas
study area, within a two-kilometer radius of each other and
participant homes. PM2.5 samples were collected onto 37 mm
polytetrafluoroethylene (PTFE) filters (Catalog #66159, Pall
Corporation, Port Washington, NY, USA) using SKC PEM PM2.5
impactors (Catalog #761-203A, SKC Inc, Eighty-Four, PA, USA).
Samplers were calibrated to run at a flow rate of 4.0 l per minute,
and operated continuously for a 7-day period of time. Flow
rates were checked at the beginning and end of the sampling
period. Gravimetric analysis of air filters was performed at JHU,
in Baltimore, MD, USA. All filters were conditioned for 24 h in
a temperature and humidity controlled room to record pre- and
post-sampling weights on a Mettler Toledo XP2U microbalance
(Mettler Toledo, Columbus, OH, USA). Data pertaining to these
filter samples are summarized in Table 1.
PM2.5 particles were eluted from PTFE filter membranes
into a solution of pyrogen-free water (PFW) (Catalog #25-055,
Mediatech Inc., Manassas, VA, USA), containing 0.05% Tween20
by volume (Catalog #BP337-500, Thermo Fisher Scientific
Inc.). Air filter samples were aseptically transferred into 12 ml
non-pyrogenic glass vials (Catalog #03-391-7D, ThermoFisher
Scientific Inc.), using clean, gloved hands and forceps. Ten
milliliters of the PFW/Tween20 solution was then pipetted into
each vial to fully submerge filters in liquid. These vials were
capped, vigorously mixed for 1 min, and then sonicated in a room
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TABLE 1 | Summary of TRPM filter samples.
Filter
samplea
Mass of PM2.5
on Filter (mg)
Ambient PM2.5 concentration
during sampling (µg/m3)
1 0.770 20
2 0.881 22
3 1.337 41
4 1.205 29
5 0.781 24
aPM2.5 samples collected continuously over 7-day periods at flow rate of 4 l per
minute.
temperature water bath (Model # 97043-964, VWR International,
West Chester, PA, USA) for 60 min. Lastly, each vial was vortexed
for 1 min and the entire volume of each of the filter eluates was
combined in a single pyrogen-free 50 ml falcon. This solution
was vortexed to thoroughly to mix the eluates, after which they
were aliquoted into sterile 10 ml cryovials and frozen at −20◦C
for shipment to the field lab in Peru. The TRPM extract used
for these WBA tests contained a particle mass concentration of
60 µg/ml, with an endotoxin content of 50 pg/ml. For reference,
Klümper et al. (2015) used a PM extract at a concentration of
100 µg/ml and a review conducted by Mitschik et al. (2008),
indicated that the most common PM extract concentrations used
for cytokine analysis in in vitro cellular studies ranged between 50
and 100 µg/ml.
Bacterial endotoxin content of the pooled TRPM extract
was quantified using a kinetic chromogenic Limulus Amebocyte
Lysate (LAL) test (Pyrochrome R© Lot #2041204, Associates of
Cape Cod Inc, E. Fallmouth, MA, USA), per the manufacturer’s
instructions. LAL testing was conducted since endotoxin is a
known pro-inflammatory agent and a contaminant of PM from
many environments (Doreswamy and Peden, 2011; Matsui et al.,
2013). The LAL lysate was reconstituted with a manufacture-
supplied buffer (Glucashield R© Lot #1207034, Associates of Cape
Cod Inc.) to block potential false-positive interference from
β-glucans in the sample matrix. Since the kinetic chromogenic
LAL test requires clear, particle-free samples for testing, 1.0 ml
aliquots of the TRPM extract were centrifuged in sterile 1.5 ml
microcentrifuge tubes at 1,000 × g for 15 min to pellet
insoluble particles. Dilutions of the TRPM extract were assayed
in duplicate in endotoxin-free 96-well tissue culture plates
(FalconTM, Corning Life Sciences, Corning, NY, USA). The LAL
testing included dilutions of control standard endotoxin from
Escherichia coli O113:H10 (concentrations of 5,000, 500, 50, 5,
and 0.5 pg/ml, Lot #249021, Associates of Cape Cod Inc.), as well
as media blanks and spiked samples. The limit of detection for the
LAL test was 15 pg/ml.
Whole Blood Collection and Incubation
Each participant provided a single blood donation for this
study. Subjects arrived at a field lab in Pampas on Sundays,
between the hours of 6 am and 10 am, where blood draws
were completed within a regular schedule to control for the
influence of circadian rhythms on whole blood cytokine release
(Hermann et al., 2006). A certified phlebotomist collected 4.0 ml
of blood into sterile blood collection tubes, which contained 75
units of sodium heparin (Catalog #367871, Becton Dickinson,
Franklin Lakes, NJ, USA). Sterile 2.0 ml cryovials were pre-
prepared on the mornings of each blood draw with 1.2 ml of
sterile RPMI 1640 + L-Glutamine/HEPES, 300 µl of stimulus
(e.g., – TRPM extract), and 300 µl of heparinized whole blood.
Diluted peripheral whole blood from each study participant
was challenged with the TRPM extract, as well as a positive
control (Purified E. coli endotoxin, concentration 100 ng/ml, Lot
#249020, Associates of Cape Cod Inc.), and a negative control
(pyrogen-free water).
Whole blood incubations were prepared and started within 1 h
of each respective participant’s blood draw. Each vial of diluted
whole blood and stimulus was gently mixed by slowly inverting
the vial threes times. These vials were then placed upright in a
thermoblock incubator (Model # 12621-108, VWR International,
West Chester, PA, USA), set to operate at 37◦C. After 24 h, the
blood samples were removed from the incubator, re-mixed, and
then aliquoted to 1.5 ml microcentrifuge tubes. The incubated
blood was immediately frozen at −20◦C and transferred on the
same day to a lab at the University of Cayetano (Lima, Peru) for
storage at−70◦C.
Aliquots of heparinized plasma were also retained following
each blood draw and were frozen at−20◦C for C-reactive protein
(CRP) analysis. Complete blood cell (CBC) counts, with a white
blood cell (WBC) differential were also completed for each
participant (Medlab, Lima, Peru). All blood and plasma samples
were then shipped on dry ice to labs at JHU and stored at−80◦C.
Cytokine and C-Reactive Protein
Analysis
Cytokine determination was conducted using the cell-free
supernatants of the whole blood incubations. Tests were
completed with a high-sensitivity electrochemiluminescent
multiplex cytokine assay and a 10-plex cytokine panel (V-PLEX
Proinflammatory Panel 1 (human) Kit, Catalog # K15049D-1,
Meso Scale Discovery, Rockville, MD, USA). This commercially
available kit measured cytokines from both the innate and
adaptive response, and was specific for Interleukin (IL)-1β, IL-6,
Tumor Necrosis Factor alpha (TNFα), IL-8, and IL-10, as well as
IL-2, IL-4, IL-13, IL-12p70, and Interferon Gamma (IFNγ). Prior
to analysis, whole blood incubation samples were thawed at room
temperature and then centrifuged at 10,000 × g for 15 min to
sufficiently pellet cellular debris and particles. The lower limits of
detection (LOD) for the assay were: IL-1β: 0.04 pg/ml, IL-6: 0.06
pg/ml, TNFα: 0.04 pg/ml, IL-8: 0.04 pg/ml, IL-10: 0.03 pg/ml, IL-
2: 0.06 pg/ml, IL-4: 0.02 pg/ml, IL-13: 0.24 pg/ml, IL-12p70: 0.11
pg/ml, IFNγ: 0.20 pg/ml. Measurements below the LOD were
assigned a value of 1/2 the respective detection limit.
C-reactive protein levels were quantified from plasma samples
with a commercial ELISA assay (Catalog # 30-9710s, ALPCO,
Salem, NH, USA), per the manufacturer’s protocol. CRP is a
biomarker of systemic inflammation and may modulate whole
blood cytokine response through complement activation and
binding of Fc gamma receptors (Du Clos, 2013). The sensitivity
of the CRP assay was 0.124 ng/ml. All cytokine and CRP analysis
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was completed in the Bayview Clinical Research Unit Core
Laboratory (Baltimore, MD, USA).
Statistical Analysis
Summary statistics, with measures of central tendency, were
computed for each subject group, with asthma subjects
dichotomized for “controlled” and “uncontrolled” asthma,
based on their respective ACT scores. Asthma Group A
contained subjects with controlled asthma and Group B
contained subjects with uncontrolled asthma. Between-group
differences were assessed with Chi-squared tests for categorical
data. Continuous variables were evaluated with non-parametric
Mann–Whitney U-tests and Kruskal–Wallis tests, with Dunn’s
multiple comparisons (when more than two groups were
evaluated). Multiple linear regression methods were also used
to compare WBA cytokine responses between participant
groups, with adjustment for age, sex, overweight/obesity status,
residential proximity to roadways, and plasma CRP. Cytokine
responses were natural-log transformed for use as a continuous
outcome in the regression analyses. Model assumptions were
assessed via residual plots and post-regression diagnostics. For all
tests, the two-sided p-value threshold for statistical significance
was set at 0.05. Statistical analysis and the creation of figures was
conducted using STATA 11.2 (STATA Corp. College Station, TX,
USA) and GraphPad Prism version 5 (GraphPad Software, La
Jola, CA, USA).
RESULTS
Study Population Characteristics
Forty-five children from Pampas were enrolled in this study.
Whole blood incubations for six of the 45 study participants were
discarded due to improper adjustment of temperature settings
on the thermoblock incubator. Thus, WBA data was available for
27 subjects with asthma and 12 controls. Summary statistics for
these participants are presented in Table 2. Those with asthma
were more likely to be male, although there was no difference in
age or BMI. Group A subjects had higher cell counts than healthy
controls for total WBC, eosinophils, and monocytes. Group B
subjects only differed from the control group by their eosinophil
count. No participants reported the use of long-term controller
medications, such as inhaled corticosteroids. One participant
with uncontrolled asthma reported use of oral corticosteroids in
the previous 2 weeks and one participant reported active cigarette
smoking upon their enrollment in the GASP cohort.
WBA Cytokine Release
Figure 2 summarizes WBA cytokine responses for all participants
(N = 39), and represents the absolute levels detected in the
cell-free supernatants of incubations. The TRPM-stimulated
release of acute phase inflammatory cytokines was measured at
levels significantly above the pyrogen-free media control for all
cytokines except IL-4, IFNγ and IL-12p70, which were therefore
excluded from further analysis. Overall, the cytokine-stimulating
potential of the TRPM extract was less potent than that of the
endotoxin control.
Table 3 summarizes TRPM, PFW, and endotoxin-stimulated
cytokine responses for healthy controls and Asthma Groups
A and B (those subjects with controlled and uncontrolled
asthma, respectively). For most cytokines, Group B subjects
were associated with the lowest cytokine responses for WBA
tests conducted with TRPM extract, while response estimates for
Group A subjects were measured at levels between those of Group
B and the healthy controls. In particular, IL-8 response levels in
TRPM-stimulated blood from Group B subjects were diminished,
in comparison to the control group (633 pg/ml vs. 1,023 pg/ml,
respectively; Mann–Whitney U-Test, p< 0.01). IL-8 estimates for
Group A subjects were also reduced from controls, but to a lesser
degree (799 pg/ml vs. 1,023 pg/ml, respectively; p = 0.10). For
WBA tests conducted with endotoxin, no clear trend in cytokine
response was evident between the asthma and control groups.
Table 4 summarizes Spearman rank-order correlation
coefficients between cytokine responses of WBA tests conducted
with endotoxin (the positive control) and TRPM. While modest
evidence of correlation exists for cytokines such at TNF-α, IL-1β,
and IL-6, there is a notable lack of correlation evident for the IL-8
responses to endotoxin and TRPM, whether the study subjects
were considered as a single group, or as sub-groups based on
asthma control status. Overall, this relationship, or lack thereof,
suggests that a participant’s IL-8 response to endotoxin was not
predictive of the IL-8 response to the TRPM extract.
Whole blood assay cytokine responses were also investigated
using multiple linear regression analysis to evaluate relationships
between asthma control status and cytokine release. We observed
no difference in the release of TNFα, IL-1β, IL-6, IL-10, IL-2,
or IL-13 between the control group and either Groups A or
B. For IL-8, subjects from Group B, with uncontrolled asthma,
had 37% (β = −0.47, e−0.47 = 0.63, p = 0.01) lower responses
(geometric mean) to TRPM stimulation than the control group,
without asthma. Group A subjects, with controlled asthma, had
an intermediate IL-8 response between control subjects and those
in Group B. There was no statistically significant difference in
TRPM-stimulated IL-8 response between subjects with Group A
and those without asthma (β=−0.28, p= 0.17).
DISCUSSION
The present study investigated the systemic immune function of
children with and without asthma through ex vivo stimulation of
peripheral whole blood immune cells. In particular, we evaluated
whether blood from individuals with uncontrolled asthma had
differential acute phase inflammatory cytokine responses to
stimulation with an aqueous extract of local study area TRPM,
compared to blood obtained from individuals with controlled
asthma or those without asthma. Ex vivo whole blood exposure
to the TRPM extract produced increased levels of acute phase
inflammatory mediators (including TNF-α, IL-1β, IL-6, IL-8) in
blood samples from all study participants.
However, contrary to our a priori hypothesis, we found
that TRPM-stimulated WBA cytokine responses were generally
equivalent across subject groups, regardless of asthma control
status. The most notable exception was for TRPM-stimulated
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TABLE 2 | Summary of participant characteristics.
Variableb Asthmaa Control group (N = 12)a p-value
Group A (N = 17) Group B (N = 10)
Age (years) 14 (11 – 17) 14 (12 – 19) 14 (11 – 17) 0.44d
Sex (M/F) 8/2 14/3 4/8 0.01c
Socioeconomic Status 0.6 (−4.4 – 1.9) −0.9 (−4.3 – 1.6) −1.2 (−3.3 – 1.7) 0.54d
Distance to road (Near/Far) 7/10 7/3 7/5 −
BMI (kg/m2) 22.6 ± 5.4 24.1 ± 4.8 23.0 ± 4.4 0.58d
CRP (µg/ml) 0.7 (0.1 – 2.1) 0.7 (0.2 – 3.8) 0.9 (0.1 – 2.6) 0.96d
Atopy, (%) 88% 73% 67% 0.60d
Cigarette smoking (N) 0 0 1 −
Oral steroid use (N) 1 0 0 −
FEV1/FVC (%)
Pre-Bronchodilator 85.3 ± 8.0 83.5 ± 9.9∗ 90.1 ± 4.0 0.08d
Post-Bronchodilator 87.2 ± 6.4∗∗ 88.5 ± 7.3∗ 93.1 ± 4.2 0.04d
FEV1 (% predicted) 102.9 ± 18.2∗ 102.5 ± 19.8 110.7 ± 20.0 0.50d
WBC count, (103 cells/µl) 8.6 (4.8 – 9.9)∗ 6.7 (3.8 – 11.1) 6.2 (5.2 – 8.9) 0.13d
Lymphocytes 2.9 (2.0 – 4.1) 2.5 (1.5 – 4.0) 2.6 (1.9 – 3.6) 0.26d
Eosinophils 0.5 (0.1 – 1.2)∗∗ 0.6 (0.11 – 1.0)∗∗ 0.3 (0.1 – 0.5) 0.01d
Monocytes 0.6 (0.3 – 0.8)∗ 0.4 (0.2 – 0.7) 0.4 (0.3 – 0.5) 0.04d
Neutrophils 3.9 (2.0 – 7.4) 3.6 (1.8 – 7.4) 3.3 (1.8 – 4.8) 0.37d
Basophils 0.0 (0.0 – 0.1) 0.0 (0.0 – 0.1) 0.0 (0.0 – 0.1) 0.76d
aGroup A, controlled asthmatics; Group B, uncontrolled asthmatics, Control group, non-asthmatics. bData are represented at Mean± SD, or median (range). cChi-square
test. dKruskal–Wallis, post test: comparison of each Asthma group to non-asthmatic group, using Dunn’s multiple comparison (∗p-value< 0.05, ∗∗p-value< 0.01). eAtopy
data not available for four asthmatic participants.
FIGURE 2 | Whole blood assay (WBA) cytokine response to 24-h stimulation with endotoxin, TRPM extract, and media control (pyrogen-free water).
TRPM-stimulated whole blood released inflammatory and anti-inflammatory cytokines at levels above the media control, but below that of the endotoxin control.
Data represent median (IQR) response for all participants (N = 39); ∗p-value < 0.05 versus media control, Kruskal–Wallis with Dunn’s post-test for multiple
comparisons (media control = reference category).
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TABLE 4 | Spearman’s correlation between TRPM and endotoxin WBA responses.
Cytokine (pg/ml)3 Spearman’s Rho for all
subjects (N = 39)
Spearman’s Rho (p-value)
Control group (N = 12) Asthma Group A (N = 10) Asthma Group B (N = 17)
TNFα 0.39 (0.01) 0.63 (0.03) 0.39 (0.26) 0.15 (0.56)
IL-1β 0.53 (0.01) 0.57 (0.05) 0.09 (<0.01) 0.40 (0.12)
IL-6 0.39 (0.01) 0.30 (0.34) 0.54 (0.11) 0.14 (0.60)
IL-8 −0.04 (0.82) −0.19 (0.56) −0.13 (0.73) 0.02 (0.93)
IL-10 0.48 (<0.01) 0.83 (<0.01) 0.88 (<0.01) 0.11 (0.68)
IL-13 0.19 (0.25) 0.29 (0.35) −0.21 (0.56) 0.11 (0.68)
IL-2 0.46 (<0.01) 0.41 (0.19) 0.67 (0.03) 0.33 (0.19)
levels of IL-8, where children with uncontrolled asthma were
found to have the lowest levels, both before and after adjusting
for age, sex, obesity/overweight status. The relationship between
IL-8 responses and the asthma control category was also not
influenced by plasma CRP levels, or residential proximity to the
study area’s major roadway. Similarly, IL-8 response estimates
for subjects with controlled asthma were less pronounced
than those of the control group, although the difference was
not statistically significant. For ex vivo WBA tests conducted
with purified bacterial endotoxin, there were no discernable
differences between groups, for any of the cytokines that were
measured.
The WBA testing conducted for this study highlighted the
capacity of the TRPM extract to potently elicit the release of
IL-8 from the human whole blood system. IL-8 is an important
inflammatory mediator, in vivo, with effects that include signaling
for chemotaxis, especially for neutrophils, and the promotion of
angiogenesis (Kunkel et al., 1991). Elevated levels of IL-8 in fluids
from the respiratory environment are closely associated with
the neutrophilic asthma phenotype, among other inflammatory
diseases (Simpson et al., 2008). However, it is also noted that
IL-8 polymorphisms have been associated with differential IL-8
gene expression and disease [e.g., - sepsis (Hu et al., 2016),
viral bronchiolitis (Pinto et al., 2016)]. In the case of asthma,
Esposito et al. (2014a) have previously reported an association
between an IL-8 polymorphism and increased odds of wheezing
among infants. Thus, we acknowledge that the genetics, and
epigenetics, of participants in this study may have influenced
the observed IL-8 responses in the WBA. Moreover, it reinforces
the complexity of the challenges associated with isolating and
evaluating the environmental, genetic, and epigenetic factors
associated with asthma.
Previous studies have shown that ambient PM provokes
the release of IL-8 from a variety of human cell types,
including airway epithelial cells and those of monocytic lineage
(Steerenberg et al., 1998; Veranth et al., 2006; Wu et al., 2014).
In vitro testing has also provided evidence to suggest that
ambient PM, with low or negligible levels of endotoxin, elicits
the release of IL-8 from immune cells through the non-canonical
activation of nuclear factor kappa beta (NFκB), primarily driven
by oxidative stress (Silbajoris et al., 2011), as opposed to pattern
recognition receptor engagement (e.g., – Toll-like Receptor 4)
(Akira et al., 2006). The TRPM samples used to develop the
extract for our study carried a low burden of endotoxin, and
thus we believe that non-endotoxin constituents in this PM were
responsible for the pro-inflammatory effects observed in our
WBA tests. We acknowledge that our current results are unable
to distinguish the specific constituents of TPRM that primarily
contribute to immunogenicity. However, as mentioned above,
TRPM is a complex mixture and a key strength of the WBA assay
is its ability to assess integrated responses to complex exposures.
Our results align with previous findings from other research
groups, who have reported attenuated IL-8 levels in sputum, nasal
lavage, and bronchoalveolar wash from TRPM-exposed subjects
with asthma, as compared to similarly exposed healthy controls
(Stenfors et al., 2004; Barraza-Villarreal et al., 2008; Behndig
et al., 2011). However, the results of our WBA testing do not
provide mechanistic support for other epidemiological studies,
which have observed an association between ambient traffic
pollution exposure and enhanced respiratory sensitivity (e.g., –
bronchoconstriction, wheeze) in asthmatic subjects (Holguin
et al., 2007; Escamilla-Nuñez et al., 2008).
In the context of the WBA model, our analysis is most
similar to that of Klümper et al. (2015), which is the only
study (to our knowledge) that has used similar whole blood
methods to assess the inflammatory effects of PM exposure in
children with and without asthma. The authors of this study
used a PM standard (collected from ambient air in Ottawa, ON,
Canada), to stimulate peripheral whole blood collected from
6-year old children, with and without asthma, who lived in
Germany. Similar to our findings, the authors observed that
whole blood stimulation with urban PM induced the release
of pro-inflammatory cytokines (including IL-6, IL-8, and TNF-
α), and no difference in responsiveness to PM stimulation was
found between children with and without asthma (Klümper et al.,
2015). Interestingly, the authors reported that among asthmatics,
NO2 exposure (estimated via a land-use regression modeled) was
positively associated with increased levels of IL-6 from urban PM-
stimulated whole blood, suggesting that chronic traffic pollutant
exposure may enhance the innate cytokine response to PM in
blood from children with asthma.
A primary limitation of the Klümper et al. (2015) study was
its small sample size, which included 27 asthmatic subjects and
59 control subjects without asthma. The design and fieldwork
for our study was conducted before publication of the Klümper
et al. (2015) study, and we emphasize that small sample size
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was also the primary limitiation of our study, which may have
limited our capacity to detect smaller differences in cytokine
responses that may have been present between subject groups.
An increased sample size, and repeat WBA testing among study
subjects would strengthen the capacity to identify differences
between subject groups. The cross-sectional approach used for
WBA testing in this study, prevented us from evaluating within-
subject variability for WBA responses over time. As a result, we
could not evaluate the temporal robustness of cytokine response
trends between asthma and controls groups, or the variability of
TRPM pro-inflammatory potential over time.
We are also mindful that our study was conducted using a
single aqueous extract of PM2.5 particles, derived from samples
collected in the community where the children lived, over a
2-week period in 2014. In one manner, the evaluation of these
children’s systemic responsiveness to TRPM derived from their
local environment was a unique strength of this study and the
results add to the existing literature base on traffic pollution
and pediatric asthma. However, we also acknowledge that the
composition of ambient PM is known to vary over time in any
single environment, and thus the pro-inflammatory potential of
PM may fluctuate as well (Manzano-León et al., 2013; Quintana-
belmares et al., 2015). The time-integrated TRPM sampling
conducted for this study may not be representative of TRPM from
other times during the year, or from other environments.
The relationship between WBA cytokine release and the
local airway responsiveness of asthmatics requires further study,
particularly given our observation of depressed IL-8 responses
to TRPM exposure in subjects with uncontrolled asthma. The
measurement of exhaled breath condensate (EBC) biomarkers
(e.g., – pH, cytokine, NO, matrix metalloproteases) may have
provided added depth to assess and contrast relationships
between WBA cytokine responses, asthma severity, peripheral
blood cell counts, and markers of airway inflammation. Previous
studies have associated a variety of EBC biomarkers with asthma
severity and lung function (Ueno et al., 2008; Karakoc et al., 2012;
Turkeli et al., 2015) While many of these EBC biomarkers remain
a developing science, they may serve as a unique complement to
WBA cytokine data, such as ours. It is important to determine
if WBA cytokine responses to environmental constituents are
predictive of airway and respiratory responsiveness to the same
exposures.
We do acknowledge that immune cells in the peripheral
circulation are relatively short-lived and have a rapid turnover,
which may not accurately mirror the reactivity status of the
airways. While our study results indicate that asthma control
was associated with a differentially lower IL-8 response to TRPM
exposure, additional mechanistic study is necessary (beyond
WBA testing) to delineate the pathways activated by complex
environmental stimuli, such as the TRPM extract used in this
study. Genotyping candidate genes in participant whole blood
would also allow for cytokine responses to be evaluated as a
function of potential genetic polymorphisms.
The literature on cytokine changes in asthma remains a subject
of debate, and serum IL-8 is regarded as a poor indicator of
disease activity in acute asthma (Tang and Chen, 2000). Our
findings of reduced release capacity of stimulated blood in
asthmatic donors might indicate that IL-8 release has “burned
out” or was counterregulated. Stenfors et al. (2004) exposed
healthy and asthmatic subjects to diesel PM and reported that
asthmatic subjects had eosinophilic, rather than neutrophilic
inflammation, and that IL-10 levels in staining of lung epithelial
cells were increased. However, we did not see significantly higher
IL-10 levels in exposed blood from our subjects, probably due to
the small sample size.
Depressed IL-8 responses in the whole blood system may
also suggest impaired cellular phagocytosis, oxidative burst, and
neutrophil chemotaxis, which could compromise the strength of
innate immune defenses against microbial infection (Mayadas
et al., 2014). If such effects extend beyond the whole blood system,
and impact localized respiratory cell populations, they may result
in compromised respiratory immune defense to infection.
CONCLUSION
This study provided insight toward the capacity of TRPM to
elicit the release of acute phase pro-inflammatory mediators from
the whole blood systems of Peruvian children. We observed
comparatively similar levels of acute inflammatory markers
(e.g., – IL-1β, IL-6, TNFα) in TRPM-stimulated whole blood
from children with and without asthma, which was contrary to
our a priori study hypothesis. However, for WBA tests conducted
with TRPM stimuli, we found that subjects with uncontrolled
asthma were associated with lower levels of IL-8, on average,
as compared to children without asthma. Although the small
sample size of our study limits definitive conclusions, the IL-
8 responses from our testing suggest that that asthma control
may be associated with the regulation of a key mediator in
neutrophil chemotaxis, at a systemic level, following exposure to
PM derived from traffic-related sources. However, there remains
a need to further evaluate the correlation between acute phase
WBA cytokine response and measures of asthmatic and non-
asthmatic airway inflammation.
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